Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We just need the latest form 4 of the each persons..
We don't know how many insiders who are on the form 4s so have to go through all of them. However any old form 4s under the name of Stone Bryan Lawrence.. we don't need them..
nope.. don’t be sorry.. i would like to help you but im driving :)
thanks again
we need to add only the last number of column 5 of the each persons form 4..
Stone Bryan Lawrence
owns total 4,746,048 shares so far according to the form 4..
also check the owners name
Adding the last number of column 5 of the each form 4 will do it.. i guess
welcome..
i do really appreciate your efforts
nag1.. thanks for the all the work
but you made a mistake with adding the wrong numbers..
Green colored numbers are what the insider bought at the time.
not the accumulated numbers..
ex) 01/31/2019 1,116,356
01/21/2108 1,000,000
There you go.. win win strategy!!
Our time will come when its ready..
all my shares are considered as retired until naz uplist..
Go $VYST
CDEL does too
Stating Fact..
.061 printed
0.0611 : 0.0625
“We started with two firms.”
Does it mean buyback program started?
Fort Myer around Ballston metro..
I was in MD, graduated UMCP
Haha what a small world..
glad to hear you
No wonder why Virginia is the one of the richest states in US.. :)
Smart investors like you make it’s possible. Haha.. guess what I’m from Arlington VA..
Watch what..?
.0521 : .0548
.50 is not the target here
5.0 is my first one and 50. is the next..
Go $VYST
Agreed..
Imo, think its true that the shrimp made vyst delayed last couple of weeks.. but now the money from the shrimp will boost vyst much quicker to dollarland.. people are smart..
News out
Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities
2/7/19, 9:18 AM
Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria.
Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and viral infections.
WORCESTER, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC: VYST) is resuming production of the Rx3000™, a hybrid air purifier designed by biomedical engineers specifically for hospitals. The Rx3000 combines powerful germicidal ultraviolet (UV) light with a patented 5-stage HEPA filtration proven in independent EPA- and FDA-certified laboratory testing to destroy on first pass over 99.97% of airborne viruses, bacteria and other contaminants. Vystar acquired the assets and patented intellectual property related to the Rx3000, RxAir™, custom filtration and other UV light air purification technologies from UV Flu Technologies in 2018 after production had stopped.
RX3000 Germicidal UV Light Air Purifier for Hospitals
The Rx3000 UV light air purification system for hospitals, which has been proven in laboratory tests to inactivate airborne pathogens, will be available in the second quarter of 2019 via Vystar’s medical distribution network.
Rx3000 is used in over 400 hospitals and is FDA-cleared as a Class II Medical Device. Priced at less than $5,000 per unit to service a 1,500 – 3,000 sq. ft. area, Rx3000 is very cost effective. Vystar also acquired all of the equipment necessary to make the custom filters used in the Rx3000. These large multi-stage filters retail for approximately $800 and last up to 1 year, depending on use. Vystar expects the first new Rx3000 units will be available to hospitals in the second quarter of 2019 via Vystar’s medical distribution network partners.
“Measles, influenza, strep, MRSA (staph), pneumonia, tuberculosis and other airborne illnesses are a major concern for hospitals and healthcare facilities year round,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center, and expert consultant for medical application and technology development. “We believe it is important that hospitals have access to the Rx3000 technology that helps reduce risk of infection from airborne antibiotic-resistant viruses and bacteria. We also encourage consumers to stay up to date on their vaccinations and follow good hygiene practices by frequently washing their hands with soap and water.”
Dr. Stone noted, “No matter how much you sanitize a room’s surfaces, it is all undone by the simple act of an infected person exhaling, sneezing or coughing harmful viruses or bacteria that can be inhaled and infect non-immune individuals. The CDC states that ‘Measles is so contagious that if one person has it, 90% of the people close to that person who are not immune will also become infected. Infected people can spread measles to others from four days before through four days after the rash appears. The Rx3000 very efficiently inactivates airborne pathogens to reduce risk of infection.”
Additional Rx3000 features include:
Patented 5-stage HEPA filtration design
Germicidal ultraviolet irradiation system
Virtually maintenance-free, with ultra quiet design
Operator-friendly controls with easy portability
HEPA and pre-filter changes in seconds
In previous measles outbreaks, hospitals looked to the Rx3000 for its UV light technology, which has been proven as an effective hospital infection control technology, as seen in the attached news clip: https://abcnews.go.com/WNT/video/measles-outbreak-13-states-23462744?tab=9482931§ion=4765066
More information on Rx3000 and consumer RxAir UV Light Air Purifiers is available at http://www.RxAir.com, 1 866.674.5238, jrotman@vytex.com
About RxAir
RxAir promotes a healthy lifestyle through the use of its innovative, patented ViraTech air purification technology, thereby improving the quality of life of each and every customer. Independently tested by EPA- and FDA-certified laboratories, the RxAir has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and VOCs. The RxAir uses high-intensity germicidal UV lamps that destroy bacteria and viruses instead of just trapping them, setting it apart from ordinary air filtration units. RxAir® and ViraTech ® are registered trademarks of UV Flu Technologies, Inc. For more information, visit http://www.RxAir.com
About Vystar Corporation:
Based in Worcester, Mass., Vystar® Corp. (OTC Pink: VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products, and the owner of RxAir UV light air purification products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. For more information, visit www.vytex.com.
Contacts:
Media: Julie Shepherd, Accentuate PR, 847 275 3643, Julie@accentuatepr.com
Investors: Steven Rotman, Vystar CEO, 508-791-9114, srotman@vytex.com
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a51592ed-a1d5-44db-b191-0cbb926a9a6c
4 Vytex Logo-size.jpg
<
Your Morgan Stanley guy... hmm
Thanks percival77 as always.
I was too busy to watch the presentation cause I worked so hard to make money to invest our co. ;)
You save my time.
Company Update on Youtube today
Money is coming in this morning...
Ready to take off?
It has been boring as we expected but the next week or the week after will be very interesting.
I’m with you. Business takes time. Happy to have Kevin as a ceo
Expect completing financial audits and filing in this month so we will hear the current status news very soon. I’m very impressed how Mr. Cornell proceeds the business in prompt manners.
Pacer update 2 days ago..
Tuesday, October 03, 2017
19 minutes Pretrial Conference Tue 3:32 PM
Minute Entry for proceedings held before Judge Lee Yeakel: Initial Pretrial Conference in Chambers held on 10/3/2017 (Minute entry documents are not available electronically). (Court Reporter Arlinda Rodriguez)(jf)
18 order Scheduling Order Tue 3:31 PM
SCHEDULING ORDER: Final Pretrial Conference set for 9/26/2018 at 10:00 AM before Judge Lee Yeakel and bench trial in the month of October 2018, ADR Report Deadline due by 2/2/2018, Discovery due by 2/28/2018, Motions due by 3/12/2018. Signed by Judge Lee Yeakel. (jf)
Posted by Ribo
Thanks Ribo
What!!! Wait for me.. mine is just a couple of millions. :)
No luck to me.. tomorrow will try again
Yes indeed..
It became a small part of ABHI’s after under Voosh management.
The fact is that we now know the lawsuit is begun..
Don’t think they have many imo.. ask is very thin today btw..
CDEL is having fun with 10000 all this morning..
10000 at .0012 CDEL ???
Playing???
Hate to see these endless dilutions but definitely changing hands for long
Vndm could be very thin like Wednesday.
Today actions were little odd imo.. just dumped by a couple of big share holders.. and most were buying..
Why didn’t they sell while they could sell at much higher prices?
Maybe dilution? Or someone just got pissed off so ruin this run?
I don’t see any reasons to sell at this level still..
Unfortunately I’m not a professional trader so just holding and keep adding..
Nah.. I added some more at .001 but not filed at .0009
wow.. finally things are going back to normal.
I’m so glad that Kevin is bring it back to where it supposed to be..